Advanced in Lung Metastases

Jie Y. Li

No.45 Changchun Street, 
Beijing, CN 
Advanced in Lung Metastases
No.45 Changchun Street, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Jie Li practices in Beijing, China. Li is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Cholera, Stomach Cancer, Osteotomy, and Endoscopy.

Their clinical research consists of co-authoring 616 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Lung Metastases.

Locations

No.45 Changchun Street, Beijing, China
Other Locations
28 Fuxing Road, Beijing, 100853, China
No. 5 Jingyuan Street, Beijing, 100043, China
No.168 Litang Road, Changping, 102218, China
Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
300 Guangzhou Road, Nanjing, 210029, China
No.9 Yard, Beiguan Street, Tongzhou, 101149, China
No. 52 Fucheng Road, Beijing, 100142, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Enrollment Status: Terminated
Publish Date: April 07, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

614 Total Publications

Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.
Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 87 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile